N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto

Abstract
This disclosure related to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.
Description
Claims
  • 1-22. (canceled)
  • 23. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound having Formula I, or pharmaceutically acceptable salts thereof, whereinQ is O, —O(C═O)—, or —O(C═O)V—;V is O, NH, or NR7;W is O;X is CH2 or CD2;Y is CR″;Z is CH;each R″ is independently selected from is H, D, F, CH3, CD3, or CF3;R1 is amino, mercapto, formyl, carboxy, carbamoyl, carbanoyl, esteryl, alkoxy, alkylamino, or (alkyl)2amino, or R1O- is selected from amide, lactam, peptide, carboxylic acid ester, or epoxide, wherein R1 is optionally substituted with one or more, the same or different, R20;Y1 is O;Y2 is OH, OR12, or OAlkyl;Y3 is OH;R2 is hydrogen;R3 is hydroxy;R4 is hydroxy, alkyl, fluoromethyl, difluoromethyl, trifluoromethyl, hydroxymethyl, or halogen;R5 is hydrogen, hydroxy, alkoxy, alkyl, fluoromethyl, difluoromethyl, trifluoromethyl, hydroxymethyl, or halogen;R6 is hydrogen;each R7 is independently selected from absent, hydrogen, —(C═O)Oalkyl, —(C═O)alkyl, —(C═O)NHalkyl, —(C═O)N-dialkyl, alkylamino, or (alkyl)2amino;R8 is hydrogen, deuterium, alkyl, alkenyl, alkynyl, halogen, cyano, hydroxy, benzyloxy, formyl, carboxy, carbamoyl, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R8 is optionally substituted with one or more, the same or different, R20;R9 is hydrogen, methyl, ethyl, tert-butyl, alkyl, higher alkyl, (C6-C16)alkyl, (C6-C22)alkyl, halogen, cyano, hydroxy, amino, formyl, carboxy, carbamoyl, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R9 is optionally substituted with one or more, the same or different, R20;R10 is hydrogen, alkyl, branched alkyl, cycloalkyl, lipid methyl, ethyl, isopropyl, cyclopentyl, cyclohexyl, butyl, pentyl, hexyl, neopentyl, benzyl, halogen, cyano, hydroxy, amino, formyl, carboxy, carbamoyl, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R10 is optionally substituted with one or more, the same or different, R20;R11 is hydrogen, deuterium, alkyl, methyl, halogen, cyano, hydroxy, amino, formyl, carboxy, carbamoyl, alkoxy, alkylthio, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl wherein R11 is optionally substituted with one or more, the same or different, R20;R12 is hydrogen, alkyl, aryl, phenyl, 1-naphthyl, 2-naphthyl, aromatic, heteroaromatic, 4-substituted phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, or naphthyl, wherein R12 is optionally substituted with one or more, the same or different, R20;R13 is hydrogen, deuterium, alkyl, alkenyl, alkynyl, halogen, cyano, hydroxy, amino, amido, formyl, carboxy, carbamoyl, lipid, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R13 is optionally substituted with one or more, the same or different, R20;R14 is hydrogen, deuterium, alkyl, alkenyl, alkynyl, halogen, cyano, hydroxy, amino, amido, formyl, carboxy, carbamoyl, lipid, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R14 is optionally substituted with one or more, the same or different, R20;R20 is deuterium, alkyl, alkenyl, alkynyl, halogen, cyano, hydroxy, amino, amido, formyl, carboxy, carbamoyl, alkoxy, alkylamino, (alkyl)2amino, (C3-C6)carbocyclyl, or aryl, wherein R20 is optionally substituted with one or more, the same or different, R21; andR21 is halogen, cyano, hydroxy, trifluoromethoxy, trifluoromethyl, amino, formyl, carboxy, carbamoyl, methyl, ethyl, methoxy, ethoxy, acetyl, acetoxy, methylamino, ethylamino, dimethylamino, diethylamino, N-methyl-N-ethylamino, acetylamino, N-methylcarbamoyl, N-ethylcarbamoyl, N,N-dimethylcarbamoyl, N,N-diethylcarbamoyl, N-methyl-N-ethylcarbamoyl, methylthio, ethylthio, methoxycarbonyl, ethoxycarbonyl, (C3-C6)carbocyclyl, or aryl;wherein the lipid comprises a C6-22 alkyl, alkoxy, polyethylene glycol, or aryl substituted with an alkyl group.
Provisional Applications (3)
Number Date Country
62201140 Aug 2015 US
62096915 Dec 2014 US
62096915 Dec 2014 US
Continuations (2)
Number Date Country
Parent 16921359 Jul 2020 US
Child 18184288 US
Parent 15537087 Apr 2018 US
Child 16921359 US